Tales of transformation logo


Tales of transformation

A life sciences and health care podcast series

This Deloitte podcast series explores trends transforming life sciences and health care. Tune in to stay a step ahead of the trends shaping the industry.

Tales of transformation podcast series

From emerging technologies to the rise of the empowered health care customer to the shift from volume to value, this series takes you to the intersection of change where tremendous transformation is happening.

Season 5: Radical interoperability and the disruption of health care

Welcome to Season 5: Radical interoperability and the disruption of health care

In this season of Tales of transformation, we explore how interoperable, always-on data will promote closer collaboration among industry stakeholders in the future of health. Not only will consumers have access to detailed information about their own health, they will own their health data and play a central role in making decisions about their health and well-being.

Episode 1: How interoperability will enable the future of health

To kick off this season of Tales of transformation, we’re exploring how radically interoperable data will promote collaboration across the health care ecosystem—and why trust will become increasingly important in this connected future.

So what exactly is “radical interoperability”? Interoperability is connecting health care data in a usable format. Radical interoperability means taking that health care data and connecting it to social information, financial and other data, and environmental factors.

It’s one thing to actually have insight in disparate, unique locations. It’s quite another when you can connect those data sets and you can actually paint a broad picture about what’s actually happening.

- Neal Batra, Principal, Deloitte Consulting LLP

Episode 2: The regulatory landscape and interoperability

Interoperability will be core to the digital future for life sciences and health care, allowing the industry to provide more effective care, reduce inefficiencies, and better meet consumers’ demands. As organizations become increasingly connected and new partnerships form, what new regulations will come into play? And how can organizations use these new rules as an opportunity to go beyond compliance and develop a strategic interoperability plan?

You’ve got the regulatory push coming and then you’ve got the consumer push. And I think those two forces together are going to be enough to really force the change and cause organizations to have to revisit their historically siloed kind of mentality.

- Jason Wainstein, Principal, Deloitte Consulting LLP

Episode 3: Interoperability in health care

In our new world of health care, data is power. And while massive investments have been made over the past 10 to 15 years to connect data throughout the industry, there are still a significant number of barriers to achieving something that’s more radically interoperable. What will it take for the health care ecosystem to get to a point where all data is integrated and easily accessible?

As these different organizations start to come together and ‘think tank’ their solutions, what they find is that there is no solution without data.

- David Biel, Principal, Deloitte Consulting LLP

Episode 4: Interoperability in life sciences

To close out our season on interoperability, we’re taking a closer look at how organizations across the life sciences industry are already making strides to improve data connectivity. So how will radical interoperability impact the products and services that life sciences companies provide? And how are less traditional industry players getting in on the action?

I’ve not seen a single organization … who doesn’t believe that the notion of interoperability is truly fundamental to what they’re trying to accomplish as an organization going forward.

- Mike DeLone, Principal, Deloitte Consulting LLP

Welcome to season 4: Risk

In the life sciences and health care industry, disruption from all angles is pushing the boundaries of what’s possible today—and what the industry could look like tomorrow. In this season of Tales of Transformation, we’ll explore some of the biggest risks that will likely be introduced in the future of health and what organizations can start doing today to tackle emerging risks and succeed in this new future.

Episode 1: Staying ahead of tomorrow’s risks

As the life sciences and health care ecosystem becomes more interconnected, what new risks will organizations face in the future of health? And what new opportunities can organizations capture by proactively managing these risks? In this episode, we explore the biggest trends shaping this new risk landscape and discuss a three-pronged strategy to help organizations manage risk.

When there’s an abundance of opportunity, there’s a race for the solution.

– Amry Junaideen, Advisory Principal, Deloitte & Touche LLP

Episode 2: Managing the risks and rewards of digital

Data will continue to play an increasingly critical role in the future of health. As data can be more widely shared, collected, and analyzed, organizations have the opportunity to create value from information that wasn’t available before—driving operational efficiencies and enhancing consumer engagement. But there’s also a downside to this proliferation of data.

In this episode, we take a closer look at the risks of digital capabilities, why organizations will need to pay closer attention to data privacy, and how the industry as a whole can begin modernizing standards to protect that valuable data.

Organizations across life sciences and health care are looking at innovative ways of analyzing, utilizing, and even commercializing their data using technologies that emulate human intuition or decision-making.

– John Lu, Advisory Principal, Deloitte & Touche LLP

Episode 3: New risks on the horizon

As new trends emerge and companies move farther along their journey toward the future of health, there are new risks that could impact many players across life sciences and health care. So how can organizations get ahead of these emerging risks? What are the opportunities for those who take a more proactive stance on risk management? And what new regulations could still be on the horizon?

If you think about the financial services industry, if I’m banking at one organization, I can still go to an ATM at another bank and get money out. That’s what they’re trying to do in the regulatory space with health care. Being able to go to another clinician and have your information there or be able to have it coordinated back to another.

– Anne Phelps, advisory principal, Deloitte & Touche LLP

Episode 4: Embracing risk

As organizations continue their journey toward the future of health, taking calculated risk could help them improve value for consumers and build competitive advantage. How can industry players better integrate risk intelligence into their overall strategy? We’re exploring three ways to manage risk and maximize opportunities—for traditional incumbents and new entrants alike.

To ensure that companies can move quickly and take advantage of [new] opportunities, they really need to be sure that the basics are solid. And that starts with enterprise safety and quality management systems.

– Jennifer Malatesta, advisory principal, Deloitte & Touche LLP

Season 3: Moving from doing digital to being digital in life sciences

Welcome to season 3: Moving from doing digital to being digital in life sciences

Digital transformation might be the buzzword of the day, but for life sciences companies it is becoming a critical imperative to succeed in a changing business environment. This season of Tales of Transformation explores digital transformation in life sciences and the challenges and opportunities companies face in moving from doing digital to being digital.

Episode 1: Digital transformation, the buzzword of the day

New technologies and digital transformation offer biopharmaceutical and medtech companies opportunities across their organizations—from how they conduct research and interact with regulators to how they optimize their finance, supply chains, and manufacturing operations. New digital capabilities can also change the game in how companies engage with their customers, patients, and other stakeholders. However, life sciences companies have not traditionally been early adopters of new technologies. What is holding life sciences companies back? How can they better take advantage of new digital capabilities? And how do they demonstrate impact and ROI from their investments?

There are fundamental building blocks that will have to be put in place—whether that's from a technology standpoint or an operating model—and so digital transformation really becomes an enabler. It becomes a bit of a risk mitigator on one hand and an accelerator of strategies on the other.

– Greg Reh, Deloitte Global Life Sciences Sector Leader

Episode 2: Who’s leading the digital change in life sciences?

Digital technologies are disrupting organizations of every size and shape, leaving many executives scrambling to find and assess the new technologies that will help their organizations compete now and in the future. Life science companies are no exception. However, while the technology itself is vital to digital transformation, the importance of strong leadership and culture cannot be overlooked. What roles do leadership and culture play in helping life sciences organizations move from simply doing digital to being digital?

You can have the best strategy in the world, but if you don’t really change the culture and the ways of working, you’re not going to pull through that strategy.

– Dave Rosner, Principal, Deloitte Consulting LLP

Episode 3: Regulatory’s impact in life sciences digital transformation

The life sciences sector already operates in one of the most regulated industries in the world. The pace of technological advancement, including the emergence of new digital health products, is adding to this complexity, and in some cases, leading to some uncertainty regarding regulators’ expectations and requirements. How will industry regulations evolve to address emerging technologies and digital capabilities?

With the introduction of a lot of disruptive, cognitive technologies, machine learning, automation, we're suddenly reaching tipping points where all of those things become far more tangible and far more real.

–Doug McKinnell, Partner, Deloitte AG

Episode 4: The consumer voice in life sciences regulatory

Consumer engagement in life sciences and health care continues to grow, from searching for care and accessing new channels of care to tracking and sharing health data and using new digital tools and technologies. How could this increased engagement spill over to the regulatory environment? Or will it?

Consumers don't like to take no for an answer. So I think that in and of itself will begin to have dramatic impact on the regulatory environment.

– Dan Ressler, Principal, Deloitte Consulting LLP

Welcome to Season 2: Exploring the future of health

Technology has transformed almost every aspect of our lives in the past 20 years, leading to large-scale disruption in many industries. Is the life sciences and health care industry next? This season of Tales of Transformation explores the future of health— a future defined by radically interoperable data; open, secure platforms; and personalized artificial intelligence that enables hyper-engaged and empowered consumers to own their journey of health.

Episode 1

Health in 2040

In 20 years, the health care industry as we know it today may no longer exist. Traditional industry boundaries are dissolving while exponential change is accelerating the pace of disruption—and propelling the industry toward a dramatically different future. One that will be defined by radically interoperable data, open yet secure platforms, and personalized artificial intelligence that will enable consumers to own their own journey of health. Tune in to this episode to learn more.

A lot of data doesn’t mean complexity. It is only complex when you don’t have the tools to understand it and the tools to change your processes. People respond very well once they have the power to understand the data at hand.

- Asif Dhar, Principal, Deloitte Consulting LLP

Episode 2

Are patients out of patience?

Tomorrow’s health care consumer won’t accept today’s limitations. And they’re becoming increasingly influential drivers of change. Listen to this episode to hear more about the transition from consumer-centric to consumer-driven care and the role that patients will play in the future of health.

What we’re seeing is consumers take ownership of their data. They’re making choices based on value and I think that’s what is driving fundamental transformation. Democratizing this data really fundamentally changes this industry.

– David Betts, Principal, Deloitte Consulting LLP

Episode 3

Is health care disruption inevitable?

The pace of disruption today is unprecedented. You don’t have to look far to see the impact of disruption in other industries—from banking to retail and travel—and health care is no exception. What trends could have the biggest impact in disrupting life sciences and health care?


There’s real oxygen in the ecosystem for someone to do it differently, to do it better. And that’s the heart of disruption.

- Neal Batra, Principal, Deloitte Consulting LLP

Episode 4

A radically interoperable future

In our “always-on” world filled with endless data, consumers have come to expect seamless, personalized experiences from every industry—and that extends to health care. But there’s a disconnect between consumer expectations and the reality of care delivery today. Tune in to this episode to hear how data interoperability could help close that gap.

Interoperability is probably one of the largest technology challenges that will really be key in opening us to a whole new frontier because it will open the aperture of how information flows.

– Casey Graves, Principal, Deloitte Consulting LLP

The explosion of data we’re experiencing now will change every aspect of health care, from delivery to consumption. Data and open platforms are the heart of the future of health and they’re enforced by the engaged consumer.
—David Betts, Principal, Deloitte Consulting LLP


Season 1: Technology trends transforming life sciences and health care

Episode 1: Digital reality

Is health care ready?

What if a patient could put aside pamphlets and actually see the impact a diet could have on his or her state of health? What if a surgeon could train or prepare for a complex procedure by simulating it first in a 360-degree 3D simulation? Digital reality is no longer only a concept attributed to the science fiction realm. The immersive technology of augmented and virtual reality is now being applied to many business applications across industries, making these scenarios increasingly realistic. Explore the potential for digital reality in life sciences and health care.

Hospitals and health care organizations and providers specifically are beginning to see real clinical utility with virtual reality (VR) and augmented reality (AR) and I like to think about that utility across a number of different categories. One is for the physician or clinician experience—that includes things where the administrative burden of being a clinician or being a physician is reduced.

– Dr. Shaun Rangappa, managing director, Deloitte Consulting LLP

Episode 2: Blockchain

Use cases in life sciences and health care

Blockchain is no longer the new technology kid on the block, but has its potential been fully realized? Or are we barely scratching the surface? What are the possibilities for blockchain—or blockchains—across the life sciences and health care industry?

When I think of the ultimate use case within the provider side of health care, it's this idea of truly having a distributed ledger of patient-level data, distributed across health systems that interact with that patient and yet the patient owns the key to that data…And so really the ultimate opportunity I think around blockchain is to have this patient data broken into blocks and distributed and managed across the health system.

– Tim Smith, principal, Deloitte Consulting LLP

Episode 3: Blockchain

Breaking down industry silos

Blockchain in life sciences and health care: Are we looking at a revolution or an evolution? This episode takes a more holistic view of how blockchain can break down industry silos and enable collaboration, coordination, and connectivity across life sciences and health care stakeholders. Learn about the opportunity for blockchain to link the industry around the spectrum of care.

We've reached a point now where I think we've gone beyond sort of the art of the possible. People are really looking to understand practically, what can I do? An interesting place for momentum is within the organization. I've seen some of our life sciences clients start to use blockchain within their internal finance organizations, to manage those processes more effectively, more efficiently, and more securely.

– Jonathon Fox, specialist leader, Deloitte Consulting LLP

Episode 4: No-collar workforce

Technology’s role in the future of work

Emerging technologies, like machine learning and artificial intelligence, are driving a shift in life sciences and health care to an augmented, no-collar workforce—a powerful collaboration between humans and technology where the unique strengths of both can be leveraged. Listen to the episode to learn more about the benefits of open talent models and the future of work in life sciences and health care.

There's been an explosion in contingent work and a movement away from the traditional employment model of full-time or even part-time as we move more to a continuum of workers and work arrangements. And so the term no-collar workforce is really a reference to this wave as of disruption and innovation and it's how we'll get work done going forward.

– Jen Radin, principal, Deloitte Consulting LLP

Episode 5: The new core

Driving operational efficiencies

Investments in “core” technology may not be the most glamorous, but they’re some of the most important. What’s driving life sciences and health care organizations to focus their resources on automating core back-office processes? Listen to this episode to learn more about the transition to a digital core and how back-end improvements can help enable front-end innovation.

Traditional supply chains are linear in nature and typically go through this structured plan source-make-deliver type of support model. And what we're seeing now with life sciences companies is that the business models are fundamentally changing…A dynamic supply network is one that allows for more efficient management of inventories, allows for increased visibility into the supply chain at each step of the process and also helps companies drive operational efficiencies.

– Todd Konersmann, principal, Deloitte Consulting LLP

Episode 6: The power of data

Transforming the future of care?

The sheer volume of data available today can often be overwhelming. But there’s a difference between available data and accessible, relevant data. The ability to access and convert relevant data into actionable insights is key to taking the power of data and analytics to the next level. Listen to this episode to explore what’s needed to unleash an insight-driven life sciences and health care industry, and how data and analytics can help reduce costs, improve quality, and increase consumer engagement.

The health care industry itself lags quite a ways behind other industries in terms of what I call data use maturity, but the question you’re really asking is, “Why is this the case?"...Health care lags not because of the technology, it lags because the industry as a whole continues to be what we call “document-centric.”

– Tony Jurek, managing director, Deloitte Consulting LLP

A life sciences and health care perspective

Tech Trends 2018

To help your business navigate digital disruption, this series provides a life sciences and health care perspective on Deloitte's 2018 Tech Trends report. From blockchain to digital reality to the no-collar workforce, explore eight trends that are shaping strategic and operational transformations and redefining life sciences and health care.

Fullwidth SCC. Do not delete! This box/component contains JavaScript that is needed on this page. This message will not be visible when page is activated.

Did you find this useful?